Ember LifeSciences reports new strategic investments boosting Series A to $27M
The investments follow after they previously announced Series A financing [...]
Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development
Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery [...]
Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development
The funding will accelerate Earendil Labs’ AI-driven R&D platform, expand [...]
Crossbow Therapeutics Raises $77 Million in Series B Financing to Advance Development of TCR-mimetic Antibody Therapies to Treat Cancer
Financing co-led by Taiho Ventures and Arkin Bio Capital with [...]
Wellpoint Invests More Than $2 Million to Strengthen Community-Based Care Across Arizona
Investments support seniors, people with disabilities, family caregivers, and the [...]
Blue Arbor Technologies Announces Strategic Partnership with Ottobock and $5 Million Investment to Advance RESTORE™ Neuromuscular Interface System
FDA breakthrough–designated RESTORE System designed to enable intuitive prosthetic control, [...]
Abram Scientific Secures $11.75M Series A Funding Led by Octapharma AG
Financing will accelerate the development of proprietary portable diagnostic platform, [...]
ProSomnus Secures $38 Million Strategic Investment from Catalio Capital Management to Scale Smart Sleep Medicine™
Strategic alliance focuses on scaling data-integrated sleep solutions to meet [...]
Simpson Interventions Announces Initial Series C Close and Rebrands as Elumn8 Medical
Series C financing supports continued clinical development of the Acolyte [...]
Johnson & Johnson Boosts U.S. Presence with $1 Billion+ Investment in Next‑Gen Cell Therapy Facility
Advanced manufacturing site will utilize cutting‑edge cell therapy technologies to [...]